Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

TXGTXG
Showing 8 of 16 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in 10x Genomics Inc Class A

AQR CAPITAL MANAGEMENT LLC holds 2M shares of TXG (10x Genomics Inc Class A), worth $74.7M as of 2026-Q2. The position was decreased (-20.2% shares). TXG represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$74.7M

Current Shares

2M

Total Value Change

+$58.3M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2M
-20.2%
$74.7M0.0%$38.34
0
2026-Q1
Decreased
2.5M
-1.6%
$53.7M0.0%$22.62
0
2025-Q4
Decreased
2.6M
-5.4%
$41.9M0.0%$16.29
0
2025-Q3
Decreased
2.7M
-34.1%
$31.5M0.0%$11.34
0
2025-Q2
Increased
4.1M
+241.3%
$47.9M0.0%$11.73
47
2025-Q1
Increased
1.2M
+134.4%
$10.6M0.0%$9.16
45
2024-Q4
Decreased
517,202
-29.1%
$7.4M0.0%$14.35
0
2024-Q3
Increased
729,032
+131.3%
$16.4M0.0%$22.67
45

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used